You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative Neoplasm (MPN)

Showing 1 - 25 of 937
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

    Withdrawn
    • Accelerated Phase MPN
    • Blast Phase MPN
    • (no location specified)
    Nov 4, 2022

    MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 16, 2023

    Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 6, 2023

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial in Chengdu (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

    Recruiting
    • Myeloproliferative Neoplasm (MPN)
    • Myelofibrosis，MF
    • flonoltinib 25mg
    • +5 more
    • Chengdu, Sichuan, China
      West China Hospital Sichuan University
    Mar 9, 2022

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Biospecimen Collection
    • +3 more
    • (no location specified)
    Oct 27, 2022

    Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Peptide-based vaccine
    • Poly ICLC
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 7, 2022

    Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

    Not yet recruiting
    • Myeloproliferative Neoplasm (MPN)
    • Myelofibrosis，MF
    • flonoltinib 25mg
    • +5 more
    • (no location specified)
    Nov 2, 2021

    MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasm
    • Azacitidine Subcutaneous Injection or Intravenous Infusion
    • +2 more
    • Miami, Florida
    • +4 more
    Jun 20, 2022

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Durham, North Carolina
      Duke University Health System
    Jan 10, 2022

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

    Completed
    • Myelodysplastic/Myeloproliferative Neoplasm
    • +2 more
    • Decidual stromal cells (DSC)
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Myeloproliferative Tumor Trial in New York (Vactosertib)

    Recruiting
    • Myeloproliferative Neoplasm
    • New York, New York
      Weill Medical College of Cornell University
    Dec 20, 2021

    Epigenetic Age on Clinic-biological Presentation and Prognosis

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Assessment of the epigenetic age
    • Bordeaux, France
      CHU de Bordeaux, service Hématologie Biologique
    Aug 28, 2023

    Myeloproliferative Neoplasms (MPN) and COVID-19

    Recruiting
    • Myeloproliferative Neoplasm
    • COVID
      • New York, New York
      • +43 more
      Apr 4, 2022

      Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Cytokine Induced Memory-like Natural Killer Cells
      • Interleukin-2
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2023

      Myeloproliferative Tumor Trial in Irvine (Diet intervention)

      Completed
      • Myeloproliferative Neoplasm
      • Diet intervention
      • Irvine, California
        University of California, Irvine
      Jun 16, 2022

      Action of Interferon in Treatment of Myeloproliferative

      Recruiting
      • Myeloproliferative Neoplasm
        • Villejuif, Ile De France, France
          Inserm U1287
        Apr 28, 2023

        Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

        Not yet recruiting
        • Myelofibrosis (PMF)
        • +2 more
        • New York, New York
          Ruttenberg Treatment Center
        Apr 18, 2023

        MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

        Recruiting
        • MDS/MPN
        • Azacitidine (AZA) with Ruxolitinib
        • Nanjing, Jiangsu, China
          The First Affiliated Hospital of Nanjing Medical University
        Apr 17, 2023

        Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

        Not yet recruiting
        • Myeloproliferative Disorders
        • Leukemia
        • Cardiac Lifestyle Program
        • Boston, Massachusetts
        • +2 more
        May 1, 2023

        Monocytes Sub-populations in Thrombosis Associated With

        Recruiting
        • Myeloproliferative Neoplasm
        • 1 additional tube of blood
        • Bordeaux, France
        • +4 more
        Nov 30, 2022

        Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

        Recruiting
        • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 18, 2022